#ESMOBreast24
#ESMOAmbassadors
ESMO - Eur. Oncology

#ESMOBreast24
#ESMOAmbassadors
ESMO - Eur. Oncology

Post-neoadjuvant therapy in patients with HR+/Her2 neg ESMO - Eur. Oncology #ESMOBreast24
#ESMOAmbassadors
Carmen Criscitiello

Do not miss the latest research findings in #BreastCancer brought to you by the #ESMOAmbassadors & become part of the conversation about the science presented at #ESMOBreast24 . #bcsm
👉 ow.ly/ILk450RE3ts

Join us at the next ESMO - Eur. Oncology Virtual Plenary session! - Giampaolo Bianchini
Elisa Agostinetto OncoAlert Evandro de Azambuja, MD, PhD

#BreastCancer #ClinicalTrial #ESMO #Metastatic #Cancer #OncoDaily #Oncology #PARP #Research

oncodaily.com/62751.html

Belgian Society of Medical Oncology newsletter is out! Kevin Punie Willem Lybaert @anneliesverbiest Barbara Hendrikx @christelfontaine @christinegennigens @cédricvanmarcke [email protected] FlorenceVanRyckeghem
canva.com/design/DAGCHZB…

The MONARCH 3 trial
Addition of abemaciclib to a nonsteroidal aromatase inhibitor (NSAI) as initial therapy for hormone receptor-positive, 🧬HER2-negative advanced #BreastCancer

✅ Significantly improved PFS and showed clinically meaningful improvement in OS

➡️ particularly

Evandro de Azambuja, MD, PhD discusses the results presented at ESMO - Eur. Oncology Virtual Plenary:
- improvement in PFS but also⬆️in toxicity;
- relatively small sample-size;
- Asian pts only (but no PARPi available in🇨🇳yet);
- results consistent according to HR status and prior platinum;
OncoAlert

#ESMOVirtualPlenary : A progression-free survival benefit was observed in women with germline BRCA1/2 mutations when treated with the #PARPi alone or in combination w/ apatinib.
Evandro de Azambuja, MD, PhD comments the results on the #ESMODailyReporter
👉dailyreporter.esmo.org/news/fuzulopar…
#mbc

Keep up to date with the latest, practice-changing publications & join the discussion with key opinion leaders in the new #ESMOVirtualJournalClub .
Check out the programme & register with yr ESMO membership: ow.ly/6TCf50Rxr4b
Evandro de Azambuja, MD, PhD Benjamin Besse Patrizia Giannatempo

🔥Join us at the next ESMO Virtual Plenary session❗️

👉Is there a new PARPi option for HER2-neg gBRCA1/2mut MBC?
👉 Does a combination of PARPi and antiangiogenic drug (apatinib) improve efficacy?
👉Are VEGFRi better than bevacizumab?

ESMO - Eur. Oncology
Evandro de Azambuja, MD, PhD

#ESMO24 : 📣Last 24 hours to submit. Watch Andres Cervantes, Rebecca Dent, Karin Jordan, Chris Verslype, Ann Partridge MD, MPH and Petros Grivas give excellent reasons to share your research. Deadline: 7 May 2024.

esmo.org/meeting-calend…

Great to see our super Ospedale San Martino Genova Università di Genova fellow Luca Arecco, MD (now research fellow at Institut Jules Bordet Instituut with Evandro de Azambuja, MD, PhD) in the list…really grateful to Conquer Cancer, the ASCO Foundation ASCO for supporting and motivating many young oncologists!
So much looking forward to #ASCO24
OncoAlert

First ESMO - Eur. Oncology Virtual Journal Club on May 22 at 630pm (CEST) - pencil down your agendas! Important data to be discussed by experts George Pentheroudakis FabriceAndre Solange Peters Andres Cervantes
esmo.org/about-esmo-mee…

📄 #ESMOGROW & 🔜 #EnLiST are 2 ESMO - Eur. Oncology initiatives with direct impact towards better #RWE generation

Very interesting #ESMOYOC #YO4YO session later today…looking forward to seeing you online !!!

ESMO - Eur. Oncology OncoAlert Maria Kfoury Véronique Debien Joseph Ciccolini Università di Genova Ospedale San Martino Genova francescalongo Evandro de Azambuja, MD, PhD Andres Cervantes

ESMO Adaptation of Lines of Systemic Therapy ( EnLiST): Evandro de Azambuja, MD, PhD Diogo Martins Branco ESMO - Eur. Oncology

Brainstorming on EnLiST, the ESMO - Eur. Oncology ESMO Adaptation of Lines of Systemic Therapy, with Chris Twelves, Kamal Saini, Miriam Koopman, Suzette Delaloze, the ESMO Real World Data Digital Working Group and individual experts from EMA FDA Industry EORTC CRO Patient Advocates

Meeting past fellows in Brussels in an ESMO - Eur. Oncology activity Franzoi Maria Alice Diogo Martins Branco KS Saini, MD Institut Jules Bordet Instituut ULB ComRecherche #fellowship

#ESMO24 : Just under 1 month left to share your research 📣 Discuss your findings with international, like-minded professionals who are shaping the future of #CancerPatient care. ⏲️ Submit your abstract by 7 May 2024. ow.ly/X51l50RcStY

Andres Cervantes Rebecca Dent